Healthicity Blog

The Department of Justice’s announcement of $6.8 billion in False Claims Act recoveries for fiscal year 2025 marks a historic high—and a clear message to healthcare organizations.

In the latest episode of Compliance Conversations, CJ Wolf interviews Clint Narver, a partner at McGuireWoods and former DOJ prosecutor, to dive deep into the world of healthcare compliance. 

It’s often said that “Individuals make decisions, not the organization.”

In September 2024, the U.S. Department of Justice (DOJ) released an updated version of their guidance document titled Evaluating Compliance Programs. This essential update impacts organizations across industries, providing a framework for how companies should assess and evolve their compliance...

As compliance professionals, staying on top of recent enforcement actions by the U.S. Department of Justice (DOJ) can be a challenge – but we’re here to help. Understanding recent enforcement actions is a crucial way to guide compliance programs, risk assessments, education efforts, and auditing...

March 2023 was an important month for compliance programs. During this time, the U.S. Department of Justice (DOJ) updated their guidance document titled “Evaluation of Corporate Compliance Programs.”¹

In October of 2022, a healthcare company pleaded guilty to engaging with a competitor to allocate employee nurses and fix the wages of those nurses. The company will pay over $130,000 as part of its sentence.

If you’ve been around the compliance block a time or two, you’ve heard various messages from enforcement agencies about their intentions to hold individuals accountable for their actions related to alleged corporate crime. It makes sense when you stop to think about it. Organizations don’t make...